Attribution of NKG2DL to the inhibition of early stage allogeneic tumors in mice

Allogeneic tumors are eventually rejected by adaptive immune responses, however, little is known about how allogeneic tumors are eradicated at the early stage of tumor development. In present study, we found that NKG2DL low expressing cancer cells were developed into palpable allogeneic tumors in mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Li, Fang, Mingli, Dong, Boqi, Guo, Sheng, Cui, Cuiyun, Liu, Jiwei, Yao, Yun, Xiao, Yue, Li, Xin, Ren, Yunjia, Meng, Xiuping, Hao, Xu, Zhao, Peiyan, Song, Yilan, Wang, Liying, Yu, Yongli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347697/
https://www.ncbi.nlm.nih.gov/pubmed/27448968
http://dx.doi.org/10.18632/oncotarget.10693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347697/
https://www.ncbi.nlm.nih.gov/pubmed/27448968
http://dx.doi.org/10.18632/oncotarget.10693

Ejemplares similares